drugset / Trial / NCT02250833

CKD-828 (80/5mg) Pharmacokinetic Study

NCT02250833

Phase 1 Completed 69 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-label, single-dose, two-period, two-way, crossover study to compare the pharmacokinetics and safety CKD-828 (Fixed Dose Combination Tablet) to coadministration telmisartan and s-amlodipine in health volunteers.

Timeline

Start
2014-09
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator S-amlodipine Unknown 5 mg Oral
Comparator Telmisartan Other / unclassified 80 mg Oral

Indications